MELISSA FUQUAY: Open Payments
NPI 1952385791 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $133 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| Valinor Pharma, LLC | 3 | $61 |
| Abbott Laboratories | 3 | $51 |
| MML US, Inc. | 1 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| TerSera Therapeutics LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
Products named: JOURNAVX, Belbuca, MOVANTIK, ETERNA, ReActiv8, RELISTOR, Prialt, Dysport.
Industry payments across IN — which companies pay providers there.
